Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ in the mechanism by which the medication is inhaled and have different instructions for use.
becoming the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years, and launched a few weeks later. Third-quarter sales of $6 ...
They may also help to identify mechanisms responsible for lung destruction in COPD, which in turn could identify new treatment targets that bronchodilators – although a mainstay of therapy ...
Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory ...
3/4 inhibitor – now given the somewhat tongue-twisting brand name of Ohtuvayre – is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD ...
AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender for market share in COPD.
Additional research addressing the connection between chronic obstructive pulmonary disease and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.The ...
Researchers used computer modeling to predict which components of cigarette smoke might be recognized by antigen-presenting molecule MR1.
A recent study published in the BMC Pulmonary Medicine unveiled a strong link between the C-reactive protein to albumin ratio ...
In acute infective exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (COPD), adding erdosteine to standard treatment significantly modified the outcome by improving the ...
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
The precise mechanism through which fluticasone furoate affects COPD and asthma symptoms is not known. Corticosteroids have been shown to have a wide range of actions on multiple cell types (eg ...